Soleno Therapeutics Inc (SLNO)

HEALTH CARE: PHARMACEUTICALS
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

1235 RADIO ROAD REDWOOD CITY, CA 94065

Soleno Therapeutics Inc operates as a pharmaceutical company.The Company develops novel therapeutic and diagnostic products for allergic rhinitis. Soleno also develops a novel diagnostic device for the detection of hemolysis.

Data as of 2020-09-12
Market Cap159.983 Million Shares Outstanding79.594 Million Avg 30-day Volume520.105 Thousand
P/E Ratio Dividend Yield EPS-0.85
Price/Sales Price cash flow ratio Price free cash flow ratio-7.5
Book Value0.71 Price to Tangible Book3.96 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.014769
BETA0.558963 52-week High/Low4.39 / 1.18 Stddev0.196522
View SEC Filings from SLNO instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.07%) 1 (0.06%) 0.0%
Funds Holding: 65 34 91.18% 24 (1.57%) 15 (0.96%) 60.0%
13F shares: 43.338 Million 20.763 Million 108.73% 24.782 Million 12.31 Million 101.31%
% Ownership 54.4724 46.459 17.25% 31.1487 27.5445 13.09%
New Positions: 41 12 241.67% 12 5 140.0%
Increased Positions 16 8 100.0% 8 1 700.0%
Closed Positions 10 1 900.0% 3
Reduced Positions 4 6 -33.33% 3 5 -40.0%
Total Calls 2.33 Million 0 1.569 Million
Total Puts 1.224 Million 0 1.212 Million
PUT/CALL Ratio 0.53 0.77
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SLNO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLNO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARIO ERNEST

  • Director
10,174 2020-07-31 4

HARRIS WILLIAM G

  • Director
5,469 2020-07-31 4

COLLINSON STUART J

  • Director
1,018 2020-07-31 3

VOLCK BIRGITTE

  • Director
6,686 2020-07-31 4

SCHULER JACK W

  • 10% Owner
15,525,904 2020-06-26 3

SINCLAIR ANDREW

  • Director
10,302,602 2020-06-26 3

ABINGWORTH LLP

  • 10% Owner
10,302,602 2020-06-26 2

FEINBERG LARRY N

ORACLE PARTNERS LP

  • 10% Owner
3,670,384 2020-06-05 1

ANISH BHATNAGAR SEE REMARKS

  • Officer
  • Director
0 2020-05-18 2

YEN KRISTEN SEE REMARKS

  • Officer
0 2020-05-18 2

HIRANO PATRICIA C SEE REMARKS

  • Officer
0 2020-05-18 2

MELINCOFF GWEN A

  • Director
0 2020-05-18 2

MACKANESS JAMES H CHIEF FINANCIAL OFFICER

  • Officer
10,000 2020-01-23 2

VIVO VENTURES V, LLC

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

  • 10% Owner
3,633,805 2019-12-02 6

BIOASIA MANGEMENT LLC

BIOASIA INVESTMENTS IV LLC

  • 10% Owner
78,798 2019-05-17 0

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-24 0

FEINBERG LARRY N

  • 10% Owner
3,683,195 2018-12-19 1

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2018-06-15 0

DALAL RAJEN

  • Director
0 2018-06-11 0

SHAH MAHENDRA

  • Director
0 2018-06-11 0

GLASHEEN JAMES WALTER

  • Director
0 2018-06-11 0

TP MANAGEMENT VII LLC

TECHNOLOGY PARTNERS FUND VII LP

TECHNOLOGY PARTNERS AFFILIATES VII LP

  • 10% Owner
8,328,900 2018-03-07 0

ENGELSEN STEINAR J

  • Director
No longer subject to file 2018-02-05 0

ENGLEMAN EDGAR

  • Director
  • 10% Owner
No longer subject to file 2018-02-05 0

KIRNON STEPHEN

  • Director
No longer subject to file 2018-02-05 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
2,388,060 2017-12-15 0

VIVO VENTURES V, LLC

  • 10% Owner
14,286,694 2017-10-02 6

O'TOOLE DAVID D

  • Director
0 2017-04-19 0

FORWARD V ASSOCIATES LLC

FORWARD VENTURES V LP

  • 10% Owner
7,173,976 2017-03-07 0

WONDKA ANTHONY SEE REMARKS

  • Officer
0 2016-06-08 0

ALEXANDER W JAMES

  • Director
No longer subject to file 2016-03-28 0

EBBERS ED SEE REMARKS

  • Officer
0 2015-05-15 0

PHELPS GINA VICE PRESIDENT OF SALES

  • Officer
0 2015-01-11 0

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

VIVO VENTURES V, LLC

BDF IV ANNEX FUND LP

BIOTECHNOLOGY DEVELOPMENT FUND IV LP

BIOTECHNOLOGY DEVELOPMENT FUND IV AFFILIATES LP

BIOASIA INVESTMENTS IV LLC

BIOTECHNOLOGY DEVELOPMENT FUND II LP

BIOASIA MANGEMENT LLC

KUNG FRANK

  • 10% Owner
609,839 2014-11-18 0

VIVO VENTURES FUND V, L.P.

CHA ALBERT

ENGLEMAN EDGAR

  • Director
  • 10% Owner
609,839 2014-11-18 0

TEKNOINVEST VIII KS

TEKNOINVEST VIII B (GP) AS

TEKNOINVEST VIII GP KS

  • 10% Owner
198,565 2014-11-12 0

NABHAN ANTOUN SEE REMARKS

  • Officer
0 2014-11-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VOLCK BIRGITTE - Director

2020-08-03 17:39:43 -0400 2020-07-31 A 6,686 $1.72 a 6,686 direct -2.1739 3.2609 6.5217 17.3913 26 -2.7174 3

HARRIS WILLIAM G - Director

2020-08-03 17:44:00 -0400 2020-07-31 A 5,469 $1.72 a 5,469 direct -2.1739 3.2609 6.5217 17.3913 26 -2.7174 3

COLLINSON STUART J - Director

2020-08-03 17:35:46 -0400 2020-07-31 A 1,018 $1.72 a 1,018 direct -2.1739 3.2609 6.5217 17.3913 26 -2.7174 3

MARIO ERNEST - Director

2020-08-03 17:41:07 -0400 2020-07-31 A 10,174 $1.72 a 10,174 direct -2.1739 3.2609 6.5217 17.3913 26 -2.7174 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments